Analyst Ratings For NASDAQ:ASND – Ascendis Pharma (NASDAQ:ASND)
Today, Wedbush reiterated its Top Pick rating on NASDAQ:ASND – Ascendis Pharma (NASDAQ:ASND) with a price target of $76.00.
Some recent analyst ratings include
- 4/20/2018-Wedbush Reiterated Rating of Top Pick.
- 4/2/2018-Leerink Swann Reiterated Rating of Mkt Perform .
- 1/19/2018-HC Wainwright Reiterated Rating of Buy.
- 9/22/2017-Wells Fargo Reiterated Rating of Buy.
Recent Insider Trading Activity For NASDAQ:ASND – Ascendis Pharma (NASDAQ:ASND)
NASDAQ:ASND – Ascendis Pharma (NASDAQ:ASND) has insider ownership of 40.00% and institutional ownership of 73.48%.
Recent Trading Activity for NASDAQ:ASND – Ascendis Pharma (NASDAQ:ASND)
Shares of NASDAQ:ASND – Ascendis Pharma closed the previous trading session at 63.97 down -1.04 1.60% with 63.779998779296875 shares trading hands.